Healthcare -
Biotechnology - NASDAQ - US
$ 158.9
1.81 %
$ 4.57 B
Market Cap
89.27
P/E
Price Target
Average
31.37%
Revenue Forecast
Estimate
18.14%
EBIT
Estimate
--33.80%
Net Income
Estimate
13.89%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Krystal Biotech, Inc.
Wall Street analysts predict an average 1-year price target for KRYS of $209 , with forecasts ranging from
a
low of
$204 to a high of $220 .
KRYS Lowest Price Target
Wall Street Target
204 USD
28.38%
KRYS Average Price Target
Wall Street Target
209 USD
31.37%
KRYS Highest Price Target
Wall Street Target
220 USD
38.45%
REVENUE FORECAST
Revenue Forecast Chart KRYS
EBIT FORECAST
EBIT Forecast Chart KRYS
NET INCOME FORECAST
Net Income Chart KRYS